🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Bioequivalence study for the fixed-dose combination of Gemigliptin/Dapaglif...
Status
Completed
Location
Jeonbuk National University Hospital
Start Date
2026-01-09
Trial ID
NCT07399470
The primary objective of this study is to evaluate the bioequivalence betwe...
Status
Completed
Location
Pharma Medica Research Inc.
Start Date
2020-12-14
Trial ID
NCT04880993
Treatments Being Tested
To evaluate the safety and pharmacokinetic characteristics of AJU-A51 in he...
Status
Completed
Location
Jang Hee Hong
Start Date
2020-08-01
Trial ID
NCT04972539
Treatments Being Tested
The study was an open-label, randomized, single-dose, two-period, two-seque...
Status
Completed
Location
PT Equilab International
Start Date
2023-03-08
Trial ID
NCT06127212
To perform a comparative evaluation on the pharmacokinetics and the safety ...
Status
Completed
Location
Clinical Research Center, H PLUS Yangji Hospital
Start Date
2022-04-28
Trial ID
NCT05411965
Treatments Being Tested
The study is to compare the rate and extent of absorption of a generic form...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-23
Trial ID
NCT06233045
Treatments Being Tested
To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, ...
Status
Not Yet Recruiting
Location
Chung-Ang University Gwangmyeong Hospital
Start Date
2025-08
Trial ID
NCT07044765
Treatments Being Tested
The aim of this study is to demonstrate bioequivalence of fixed dose combin...
Status
Completed
Location
Research Site
Start Date
2016-03-30
Trial ID
NCT02722239
Treatments Being Tested
This is a bioequivalence study to compare 2 fixed-dose combination tablets ...
Status
Completed
Location
Research Site
Start Date
2015-12-21
Trial ID
NCT02637037
The objective of this study is to evaluate the efficacy on glycemic variabi...
Status
Completed
Location
Samsung Medical Center
Start Date
2017-08-09
Trial ID
NCT03202563